Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-09

Clinical Trial Update: Biological and Clinical Efficacy of Shingrix in Patients With CLL [NA]

View source ↗

Summary

Registry entry describing a trial to assess the biological and clinical efficacy of Shingrix in patients with chronic lymphocytic leukemia and related condition…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Shingrix (recombinant zoster vaccine, adjuvanted)

Snippet

Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto | Conditions: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | NA | Status: NOT_YET_RECRUITING